Holen Sie sich die Stockscreener-App
1.48
0.68%
0.01
Handel nachbörslich:
1.53
0.05
+3.38%
Schlusskurs vom Vortag:
$1.47
Offen:
$1.47
24-Stunden-Volumen:
96,078
Relative Volume:
0.59
Marktkapitalisierung:
$10.23M
Einnahmen:
$3.19M
Nettoeinkommen (Verlust:
$-10.42M
KGV:
-0.0417
EPS:
-35.4757
Netto-Cashflow:
$-10.65M
1W Leistung:
+0.68%
1M Leistung:
-34.22%
6M Leistung:
-33.03%
1J Leistung:
+30.40%
1-Tages-Spanne:
$1.432
$1.515
1-Wochen-Bereich:
$1.375
$1.54
52-Wochen-Spanne:
$1.0701
$3.00
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Firmenname
Intelligent Bio Solutions Inc
Sektor
Branche
Telefon
646-790-5756
Adresse
135 W 41ST ST,, NEW YORK
Vergleichen Sie INBS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
1.48 | 11.15M | 3.19M | -10.42M | -10.65M | -35.48 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Intelligent Bio Solutions Inc Aktie (INBS) Neueste Nachrichten
Intelligent Bio : Investor Deck - MarketScreener
Intelligent Bio : Fourth Quarter 2025 Fiscal Fourth Quarter 2025 Press Release - MarketScreener
Intelligent Bio Solutions Inc. shares rise 2.00% intraday after Bio-Works' largest shareholders plan to exercise warrants. - AInvest
Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July - The Manila Times
Record-Breaking 12,500 Units: Intelligent Bio Solutions Hits All-Time High in Drug Test Cartridge Sales - Stock Titan
Intelligent Bio Solutions Inc. shares rise 2.72% intraday after Bio-Works CEO and board members plan to exercise warrants. - AInvest
Intelligent Bio Solutions' Earnings Turnaround: A Deep Dive into a Biotech Rebound Opportunity - AInvest
Intelligent Bio Solutions FY 2025 Earnings: US$2.00 Loss per Share - AInvest
Intelligent Bio Solutions Full Year 2025 Earnings: US$2.00 loss per share (vs US$6.38 loss in FY 2024) - Yahoo Finance
Intelligent Bio Solutions Inc. Hits Oversold Level on RSI Indicator2025 Biggest Moves & Weekly High Return Forecasts - newsyoung.net
Intelligent Bio Solutions: A High-Risk, High-Reward Play on FDA Clearance and Global Drug Testing Expansion - AInvest
Intelligent Bio 2025 Q4 Earnings Mixed Results with Narrowed Losses - AInvest
Intelligent Bio Solutions reports FY25 EPS ($2.00) vs. ($6.38) last year - TipRanks
Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies - The Manila Times
INTELLIGENT BIO SOLUTIONS INC. SEC 10-K Report - TradingView
Intelligent Bio Solutions Reports Q4 16% Revenue Growth, Expands US Market. - AInvest
16% Revenue Growth: Intelligent Bio Solutions Expands to 450+ Customers Across 24 Countries in Drug Testing - Stock Titan
Intelligent Bio Solutions Inc. Nearing Breakout Level After Bounce2025 Short Interest & Momentum Based Trading Signals - kangso.co.kr
Will Intelligent Bio Solutions Inc. Recover After Recent DeclineWeekly Trend Summary & Risk Controlled Daily Plans - mustnews.co.kr
Intelligent Bio Solutions shares rise 1.39% intraday after announcing participation in Sidoti Micro-Cap Virtual Conference. - AInvest
Intelligent Bio Solutions to participate in Sidoti Micro-Cap Virtual Conference. - AInvest
Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025 - MarketScreener
Intelligent Bio Solutions CEO Reveals Growth Strategy at Exclusive Sidoti Conference - Stock Titan
Is Intelligent Bio Solutions Inc. the Top Chart Pick This WeekHigh Win Rate Trading Opportunities Detected - beatles.ru
Intelligent Bio Solutions shares rise 4.52% after-hours after reporting strong Q4 revenue growth and U.S. FDA 510(k) clearance progress. - AInvest
Intelligent Bio Solutions reports double-digit revenue growth in Q4 and FY23. - AInvest
Intelligent Bio Solutions Inc. shares fall 1.28% intraday after reporting preliminary fiscal fourth quarter revenue growth of 16%. - AInvest
Intelligent Bio Solutions Submits Key FDA Information - The Globe and Mail
Intelligent Bio Solutions: A High-Conviction Play on Recurring Revenue and U.S. Market Breakout Potential - AInvest
Intelligent Bio Reports Strong Q4 Revenue Growth and Operational Momentum - TradingView
Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum - The Manila Times
Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Qu - GuruFocus
Intelligent Bio Solutions Expects 16% YoY Growth in Q4 Revenue - AInvest
INBS Expects 16% Q4 Sequential, YoY Revenue Growth, Advances FDA Clearance - AInvest
EXCLUSIVE: Intelligent Bio Expects Double Digit Topline Growth In Q4 - Yahoo Finance
Intelligent Bio Solutions shares rise 2.56% after-hours after strengthening FDA 510(k) package with new cybersecurity and performance data. - AInvest
Intelligent Bio Solutions submits FDA response for drug screening tech By Investing.com - Investing.com Canada
Intelligent Bio Solutions submits FDA response for drug screening tech - Investing.com
Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch - MarketScreener
INBS submits new data to FDA for 510(k) clearance of fingerprint drug screening tech. - AInvest
Intelligent Bio Solutions Strengthens FDA 510(k) Package with Ne - GuruFocus
Intelligent Bio Solutions submits Additional Information to FDA for 510(k) clearance. - AInvest
Massive FDA Data Package: Bio Solutions' Drug Test Aims for Quick Approval After 10,000 Hours of Testing - Stock Titan
Intelligent Bio Solutions Inc. shares rise 2.04% intraday after Eni and LG Chem launch sustainable fuel plant in South Korea. - AInvest
What drives Intelligent Bio Solutions Inc. stock priceFree Technical Analysis Support - Jammu Links News
When is Intelligent Bio Solutions Inc. stock expected to show significant growthInvest like a pro with expert recommendations - Jammu Links News
What catalysts could drive Intelligent Bio Solutions Inc. stock higher in 2025Invest smarter with actionable stock recommendations - Jammu Links News
What institutional investors are buying Intelligent Bio Solutions Inc. stockGet real-time alerts on high-potential stocks - Jammu Links News
Why Intelligent Bio Solutions Inc. stock attracts strong analyst attentionLow Risk Swing Trade Opportunities Identified - beatles.ru
Should I hold or sell Intelligent Bio Solutions Inc. stock in 2025Find market-beating stocks for your portfolio - Jammu Links News
Does Intelligent Bio Solutions Inc. stock perform well during market downturnsUnlock expert trading strategies for growth - Jammu Links News
Finanzdaten der Intelligent Bio Solutions Inc-Aktie (INBS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):